Serum folate, vitamin B12, and homocysteine in major depressive disorder, part 2: Predictors of relapse during the continuation phase of pharmacotherapy

Journal of Clinical Psychiatry

Volumn 65, Issue 8, 2004, Pages 1096-1098

  Papakostas, George I ^a   Petersen, Timothy ^a   Mischoulon, David ^a   Green, Cassandra H ^a   Nierenberg, Andrew A ^a   Bottiglieri, Teodoro ^b   Rosenbaum, Jerrold F ^a   Alpert, Jonathan E ^a   Fava, Maurizio ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b Houston   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYANOCOBALAMIN; FLUOXETINE; FOLIC ACID; HOMOCYSTEINE; SEROTONIN UPTAKE INHIBITOR;

ADULT; AMBULATORY CARE; ARTICLE; BLOOD; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DRUG ADMINISTRATION; FEMALE; FOLLOW UP; HUMAN; MALE; PROBABILITY; PSYCHOLOGICAL RATING SCALE; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; TREATMENT OUTCOME;

ADULT; AMBULATORY CARE; DEPRESSIVE DISORDER; DRUG ADMINISTRATION SCHEDULE; FEMALE; FLUOXETINE; FOLIC ACID; FOLLOW-UP STUDIES; HOMOCYSTEINE; HUMANS; MALE; PROBABILITY; PSYCHIATRIC STATUS RATING SCALES; RECURRENCE; SEROTONIN UPTAKE INHIBITORS; TREATMENT OUTCOME; VITAMIN B 12;

EID: 4544255446     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v65n0811     Document Type: Article

References (7)

1. 12, and homocysteine in major depressive disorder. Am J Psychiatry 1997;154:426-428
2. 12, and homocysteine in major depressive disorder, part 1: predictors of clinical response in fluoxetine-resistant depression. J Clin Psychiatry 2004;65:1090-1095
3. Frank E, Prien RF, Jarrett RB, et al. Conceptualization and rationale for consensus definitions of terms in major depressive disorder: remission, recovery, relapse, and recurrence. Arch Gen Psychiatry 1991;48:851-855
4. Perlis RH, Nierenberg AA, Alpert JE, et al. Effects of adding cognitive therapy to fluoxetine dose increase on relapse and residual depressive symptoms on continuation treatment of major depressive disorder. J Clin Psychopharmacol 2002;22:474-480
5. Fawcett J, Epstein P, Fiester SJ, et al. Clinical management: imipramine/ placebo administration manual. Psychopharmacol Bull 1987;23:309-323 (Pubitemid 18050023)
6. Fava M, Alpert J, Nierenberg A, et al. Double-blind study of high-dose fluoxetine versus lithium or desipramine augmentation of fluoxetine in partial responders and nonresponders to fluoxetine. J Clin Psychopharmacol 2002;22:379-387 (Pubitemid 34810327)
7. Coppen A, Chaudhry S, Swade C. Folic acid enhances lithium prophylaxis. J Affect Disord 1986;10:9-13 (Pubitemid 16109820)